LB705 is a comprehensive medical cannabis bill that would substantially revise Nebraska’s existing medical cannabis framework and create several new statutory schemes. It amends the Nebraska Medical Cannabis Patient Protection Act and the Nebraska Medical Cannabis Regulation Act, and it adds the Nebraska Medical Cannabis Justice Act and the Cannabis Conviction Clean Slate Act. The bill defines key terms, establishes patient and caregiver protections, creates a registry program and registry cards, and sets out rules for lawful possession, use, transport, and delivery of medical cannabis for qualified patients and registered caregivers.
The bill also builds a full regulatory structure for licensing and oversight of the medical cannabis industry. It creates the Nebraska Medical Cannabis Commission, largely tied to the Nebraska Liquor Control Commission, and gives it authority over licensing, inspections, testing, packaging, labeling, security, recordkeeping, enforcement, and rulemaking. The bill authorizes multiple license types, including cultivator, dispensary, patient delivery, products manufacturer, testing facility, and transporter, and it includes provisions for local zoning, school setbacks, license fees, renewals, transfers, and penalties. It also creates dedicated funds for administration and equity-related programs, and it directs agencies to provide technical assistance, grants, training, and reinvestment support.
LB705 would also change Nebraska criminal law and collateral consequences related to cannabis. It revises controlled substances and drug paraphernalia provisions to carve out conduct authorized under the medical cannabis laws, and it creates protections against arrest, prosecution, employment discrimination, and certain housing or licensing consequences for lawful medical cannabis activity. The bill further establishes a justice component that would allow people with certain eligible cannabis convictions to seek resentencing or clean slate relief, and it provides for automatic eligibility and record-sealing-style relief for some offenses. It also addresses medical cannabis access for Medicaid-eligible patients and includes provisions related to financial institutions, contracts, and attorney discipline.
The general sentiment reflected in the bill’s structure is strongly supportive of a regulated medical cannabis market with patient access and social equity goals. Even without committee transcripts or recorded votes, the breadth of the bill suggests an affirmative policy approach: it emphasizes patient protections, industry licensing, public health safeguards, and reinvestment in communities affected by cannabis prohibition. At the same time, the bill’s final status as indefinitely postponed indicates that it did not advance, which is consistent with a measure that likely faced significant legislative resistance or was too expansive to secure final approval.
The main points of contention are likely to have involved the scope of legalization, the size and complexity of the regulatory system, and the criminal-justice relief provisions. The bill goes beyond patient access by creating a large licensing regime, local control provisions, social equity preferences, and conviction relief mechanisms, all of which could draw objections from lawmakers concerned about implementation, enforcement, public safety, local zoning authority, or the policy implications of cannabis reform. The inclusion of medical cannabis justice and clean slate provisions may also have been controversial for members who support medical access but oppose retroactive relief or broader changes to controlled-substance law.
LB705 would significantly amend Nebraska statutes governing medical cannabis, controlled substances, drug paraphernalia, licensing, local regulation, and criminal record relief. It would create new statutory chapters for medical cannabis regulation, medical cannabis justice, and cannabis conviction clean slate relief, while also revising existing criminal and regulatory provisions to exempt authorized medical cannabis conduct from state penalties. The bill would establish new state agencies, funds, licensing categories, and compliance requirements, and it would affect patients, caregivers, dispensaries, cultivators, manufacturers, testing facilities, transporters, local governments, courts, and criminal justice agencies.
The bill appears to have been introduced as a major pro-medical-cannabis reform measure with strong patient-access, regulatory, and equity themes. Its detailed protections and new programs suggest support for a structured legal market rather than a limited carveout. However, the fact that it was indefinitely postponed indicates that the proposal did not ultimately command enough legislative support to advance, suggesting substantial hesitation or opposition to the bill’s breadth and policy changes.
Likely points of contention include whether Nebraska should adopt a full medical cannabis market at all, how much authority the state commission versus local governments should have, and whether the bill’s social equity and conviction-relief provisions go too far beyond patient access. Opponents may have objected to the creation of a broad licensing system, the use of public funds for grants and reinvestment programs, and the automatic or petition-based clean slate relief for prior cannabis offenses. Supporters would likely have emphasized patient protections, regulated access, and restorative justice, while critics would likely have focused on implementation burdens, public safety concerns, and local control.